bioMérieux (OTC: BMXMF)
$111.00
(-0.5%)
-$0.60
Price as of April 16, 2024, 9:30 a.m. ET
bioMérieux Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
bioMérieux Company Info
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.